epocrates logo
epocrates logo
epocrates logo
  • 0

Interaction Check

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Selected Drugs Clear All

  • remove Koselugo
    selumetinib
  • remove Nulojix
    belatacept
  • remove Virtussin DAC
    codeine/ pseudoephedrine/ guaifenesin

multicheck MultiCheck Results - 0 Interaction

Smiley face Smiley face

Additional Considerations

Smiley face Smiley face selumetinib in Koselugo

avoid supplemental vitamin E if daily vitamin E intake greater than recommended or safe limits; combo may incr. risk of bleeding; additive effects, antiplatelet and anticoagulant effects augmented by vitamin E content in selumetinib capsules

Smiley face Smiley face codeine in Virtussin DAC

consider prescribing an opioid overdose reversal agent, especially with concomitant CNS depressant use

add MAO inhibitor to Interaction Check if recent (14 days) use

Smiley face Smiley face pseudoephedrine in Virtussin DAC

add MAO inhibitor to Interaction Check if recent (14 days) use

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback Cookie Preferences
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information